adamantylamide-alanyl-isoglutamine has been researched along with Orthomyxoviridae Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masek, K; Masihi, KN; Palache, B; Rohde-Schulz, B | 1 |
Gast, G; Huchshorn, P; Lange, W; Masek, K; Masihi, KN; Palache, A; Schwenke, S | 1 |
1 review(s) available for adamantylamide-alanyl-isoglutamine and Orthomyxoviridae Infections
Article | Year |
---|---|
Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Dipeptides; Hypersensitivity, Delayed; Immunity, Cellular; Influenza Vaccines; Mice; Orthomyxoviridae Infections | 1992 |
1 other study(ies) available for adamantylamide-alanyl-isoglutamine and Orthomyxoviridae Infections
Article | Year |
---|---|
Effect of immunomodulator adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aerosols; Aluminum Hydroxide; Amantadine; Animals; Antibodies, Viral; Cross Reactions; Dipeptides; Female; Hemagglutination Inhibition Tests; Influenza A virus; Influenza B virus; Influenza Vaccines; Mice; Orthomyxoviridae Infections; Vaccination | 1990 |